Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ana Flávia Tostes"'
Autor:
Marcella Goetz MORO, Paula Katherine Vargas SANCHEZ, Mayara Vitorino GEVERT, Emeline Maria BALLER, Ana Flávia TOSTES, Ana Caroline LUPEPSA, Sinvaldo BAGLIE, Gilson Cesar Nobre FRANCO
Publikováno v:
Brazilian Oral Research, Vol 30, Iss 1
Abstract The consumption of low-dose aspirin (LDA) to prevent cardiovascular disease continues to increase worldwide. Consequently, the number of chronic LDA users seeking dental procedures that require complementary acute anti-inflammatory medicatio
Externí odkaz:
https://doaj.org/article/e957edcff27a4546975c587792b6b67c
Autor:
Guilherme Lopes-Gonçalves, Juliana Martins Costa-Pessoa, Ruan Pimenta, Ana Flavia Tostes, Eloisa Martins da Silva, Felipe Lourenço Ledesma, Denise Maria Avancini Costa Malheiros, Roberto Zatz, Karina Thieme, Niels Olsen Saraiva Câmara, Maria Oliveira-Souza
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Focal segmental glomerulosclerosis (FSGS) is the leading cause of nephrotic syndrome, which is characterized by podocyte injury. Given that the pathophysiology of nondiabetic glomerulosclerosis is poorly understood and targeted therapies to
Externí odkaz:
https://doaj.org/article/7c2b6a9725664b6681f6b38bddc8992b
Autor:
Ana Caroline Lupepsa, Emeline Maria Baller, Ana Flávia Tostes, Sinvaldo Baglie, Marcella Goetz Moro, Paula Katherine Vargas Sanchez, Gilson Cesar Nobre Franco, Mayara Vitorino Gevert
Publikováno v:
Brazilian Oral Research, Vol 30, Iss 1
Brazilian Oral Research v.30 n.1 2016
Brazilian Oral Research
Sociedade Brasileira de Pesquisa Odontológica (SBPqO)
instacron:SBPQO
Brazilian Oral Research, Volume: 30, Issue: 1, Article number: e127, Published: 28 NOV 2016
Brazilian Oral Research v.30 n.1 2016
Brazilian Oral Research
Sociedade Brasileira de Pesquisa Odontológica (SBPqO)
instacron:SBPQO
Brazilian Oral Research, Volume: 30, Issue: 1, Article number: e127, Published: 28 NOV 2016
The consumption of low-dose aspirin (LDA) to prevent cardiovascular disease continues to increase worldwide. Consequently, the number of chronic LDA users seeking dental procedures that require complementary acute anti-inflammatory medication has als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894f9c969ae55e4a70c20b71f6da19ab
https://doi.org/10.1590/1807-3107bor-2016.vol30.0127
https://doi.org/10.1590/1807-3107bor-2016.vol30.0127
Autor:
Francine Alessandra Manente, Ana Flavia Tostes da Silva, Josiane Aparecida Schemberger, Isabella Aparecida Heinrich, Antonio Carlos Mattar Munhoz, Flávio Luis Beltrame, Danielle Cardoso Geraldo Maia, Ana Carolina Urbaczek, Iracilda Zeppone Carlos, José Carlos Rebuglio Vellosa
Publikováno v:
Revista de Ciências Farmacêuticas Básica e Aplicada, Vol 34, Iss 4, Pp 679-685 (2014)
A anfotericina B (AmB) é fármaco “padrão ouro” para o tratamento de infecções fúngicas invasivas desde 1960, Entretanto, a anfotericina B apresenta elevada toxicidade, a qual manifesta-se mais frequentemente nos rins e no fígado, Sabe-se,
Externí odkaz:
https://doaj.org/article/61f00f1729b145f9a574a40934cf25f1